Citation:Kudoh S, Takeda K, Nakagawa K, Takada M, Katakami N, Matsui K, et al 2006

Citation

Kudoh S, Takeda K, Nakagawa K, Takada M, Katakami N, Matsui K, et al. Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904). J Clin Oncol 2006 Aug 1;24(22):3657-63 Available from: http://www.ncbi.nlm.nih.gov/pubmed/16877734.

Critical appraisals

• Assign a critical appraisal

Critical appraisal link	Clinical question	Assigned to	Status
Kudoh S, Takeda K, Nakagawa K, Takada M, Katakami N, Matsui K, et al 2006	What is the optimal systemic therapy for stage IV inoperable NSCLC?	Assoc. Prof. Nick Pavlakis	completed
Kudoh S, Takeda K, Nakagawa K, Takada M, Katakami N, Matsui K, et al 2006 2	What is the optimal systemic therapy regimen for elderly patients for treatment of stage IV inoperable NSCLC?	Assoc. Prof. Nick Pavlakis	completed

Compare quality appraisals for each clinical question

• [[Clinical question:What is the optimal systemic therapy for stage IV inoperable NSCLC?|]] (compare critical appraisals)
• [[Clinical question:What is the optimal systemic therapy regimen for elderly patients for treatment of stage IV inoperable NSCLC?|]] (compare critical appraisals)

Cited by

1. What is the optimal systemic therapy for stage IV inoperable NSCLC?
2. What is the optimal systemic therapy regimen for elderly patients for treatment of stage IV inoperable NSCLC?